Not applicableWithdrawnNCT00657332What this trial is testingClinical and Pathologic Studies in Neuroendocrine TumorsWho this might be right forCarcinoid TumorNeuroendocrine Tumors Stanford University
Large-scale testing (Phase 3)Ended earlyNCT00092287What this trial is testingComparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid SyndromeWho this might be right forMalignant Carcinoid Syndrome Ipsen 4
Testing effectiveness (Phase 2)Study completedNCT03453489What this trial is testingAMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine NeoplasmWho this might be right forCarcinoid SyndromeMetastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm Barbara Ann Karmanos Cancer Institute 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT03950609What this trial is testingLenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid TumorsWho this might be right forAdvanced Carcinoid TumorDigestive System Neuroendocrine NeoplasmMultiple Endocrine Neoplasia Type 1+2 more M.D. Anderson Cancer Center 36
Early research (Phase 1)Study completedNCT01048892What this trial is testingSeneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine FeaturesWho this might be right forAdrenocortical CarcinomaGastrointestinal Carcinoid TumorKidney Cancer+3 more Children's Oncology Group 22
Large-scale testing (Phase 3)UnknownNCT01373736What this trial is testing123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine TumorsWho this might be right forPheochromocytomaNeuroblastomaParaganglioma+2 more Vancouver Coastal Health
Post-approval studies (Phase 4)Ended earlyNCT04140409What this trial is testingSandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation OptimisationWho this might be right forNeuroendocrine TumorsCarcinoid Syndrome Cliniques universitaires Saint-Luc- Université Catholique de Louvain 10
Not applicableActive Not RecruitingNCT03583528What this trial is testingDOTATOC PET/CT for Imaging NET PatientsWho this might be right forNeuroendocrine TumorsInsulinomaGastrinoma+13 more British Columbia Cancer Agency 800
Not applicableStudy completedNCT03817866What this trial is testingChromogranin A as Blood Marker in Cancer PatientsWho this might be right forGastric NeoplasmsPancreatic NeoplasmsSmall Intestinal Neoplasms+1 more Brahms AG 175
Very early researchWithdrawnNCT03623984What this trial is testingMolecular-Guided Surgery for Pancreatic and GI Neuroendocrine CancersWho this might be right forNeuroendocrine Carcinoma of PancreasCarcinoid University of Alabama at Birmingham
Testing effectiveness (Phase 2)Ended earlyNCT03420521What this trial is testingNivolumab With Ipilimumab in Subjects With Neuroendocrine TumorsWho this might be right forNeuroendocrine TumorsCarcinoid Tumor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Testing effectiveness (Phase 2)Study completedNCT00131911What this trial is testingSorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+7 more National Cancer Institute (NCI) 93
Not applicableLooking for participantsNCT00646022What this trial is testingNatural History of Familial Carcinoid TumorWho this might be right forCarcinoid National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1,600
Early research (Phase 1)Study completedNCT03879694What this trial is testingSurvivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine TumorsWho this might be right forLung Atypical Carcinoid TumorLung Typical Carcinoid TumorMetastatic Pancreatic Neuroendocrine Tumor Roswell Park Cancer Institute 19
Large-scale testing (Phase 3)WithdrawnNCT01860742What this trial is testingRandomized Phase III of PRRT Versus InterferonWho this might be right forGastro-intestinal Neuroendocrine Tumors Jules Bordet Institute
Not applicableUnknownNCT05448157What this trial is testing68Ga-DOTATOC Radio-Guided Surgery With β-Probe in GEP-NETWho this might be right forNeuroendocrine Tumor CarcinoidNeuroendocrine Tumor of PancreasGep Net European Institute of Oncology 20
Testing effectiveness (Phase 2)Study completedNCT00363051What this trial is testingSafety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to ChemotherapyWho this might be right forIslet Cell CarcinomaNeuroendocrine CarcinomaNeuroendocrine Tumor+1 more Novartis Pharmaceuticals 160
Testing effectiveness (Phase 2)Study completedNCT00113360What this trial is testingRAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine CarcinomaWho this might be right forNeuroendocrine CarcinomaIslet Cell Carcinoma M.D. Anderson Cancer Center 67
Early research (Phase 1)Study completedNCT00005860What this trial is testingOxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT04276597What this trial is testingPhase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.Who this might be right forPulmonary Neuroendocrine NeoplasmPheochromocytomaParaganglioma+7 more Excel Diagnostics and Nuclear Oncology Center